SR
Satynarayan Ruhela
About Satynarayan Ruhela
Data last updated:
Satynarayan Ruhela is a Director at Sormed Pharma Private Limited (since 2024). The companies operate in Pharma. Earlier, Satynarayan Ruhela was a Director at Dr. Fin Balor Laboratories Private Limited (2022–2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 12 Sep 2024 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 27 Apr 2022 | 2022 | ₹21.9 Lakh (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Satynarayan Ruhela
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sheela | 09588449 | Sormed Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Satynarayan Ruhela
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Satynarayan Ruhela
Satynarayan Ruhela currently holds 1 directorship: Sormed Pharma Private Limited (Director, since 12 Sep 2024).
Satynarayan Ruhela was first appointed on 27 Apr 2022 as Director at Dr. Fin Balor Laboratories Private Limited. The most recent appointment on record is 12 Sep 2024 at Sormed Pharma Private Limited.
Satynarayan Ruhela held 1 earlier board appointment: Dr. Fin Balor Laboratories Private Limited (Director, 27 Apr 2022 to 10 Jun 2024).
The current boards of Satynarayan Ruhela's companies include Sheela (Sormed Pharma Private Limited).